Evolving regulatory landscape with erythropoiesis-stimulating agents and impact on managed care. [electronic resource]
Producer: 20100629Description: S74-9 p. digitalISSN:- 1936-2692
- Anemia -- drug therapy
- Cardiovascular Diseases -- chemically induced
- Drug and Narcotic Control
- Drug-Related Side Effects and Adverse Reactions
- Hematinics -- adverse effects
- Humans
- Insurance, Health, Reimbursement
- Kidney Failure, Chronic -- complications
- Managed Care Programs
- Neoplasms -- complications
- Product Surveillance, Postmarketing
- Risk Assessment
- Stroke -- chemically induced
- United States -- epidemiology
- United States Food and Drug Administration
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.